Filtros de búsqueda

Lista de obras de Beatrice Mohelnikova-Duchonova

ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.

artículo científico publicado en 2013

Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population ⬇️

artículo científico publicado el 1 de noviembre de 2010

Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients

artículo científico publicado en 2016

Bevacizumab with FOLFIRI or XELIRI in the First-line Therapy of Metastatic Colorectal Carcinoma: Results from Czech Observational Registry

artículo científico publicado en 2015

Biomarkers and pathways of chemoresistance and chemosensitivity for personalized treatment of pancreatic adenocarcinoma

scientific article published on 12 December 2018

CHEK2 gene alterations in the forkhead-associated domain, 1100delC and del5395 do not modify the risk of sporadic pancreatic cancer.

artículo científico publicado en 2010

CYP2A13, ADH1B, and ADH1C gene polymorphisms and pancreatic cancer risk

artículo científico publicado en 2010

Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer

artículo científico publicado en 2015

Cost analysis of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and the risk factors for their increased cost in a public insurance health care system - Single centre study

scientific article published on 17 January 2020

Differences in transcript levels of ABC transporters between pancreatic adenocarcinoma and nonneoplastic tissues.

artículo científico publicado en 2013

Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature

artículo científico publicado en 2017

Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation

artículo científico publicado en 2017

Downregulation of ABC Transporters in Non-neoplastic Tissues Confers Better Prognosis for Pancreatic and Colorectal Cancer Patients

artículo científico publicado en 2017

Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome.

artículo científico publicado en 2017

Evaluation and management of toxicity of cytoreductive surgery/hyperthermic intraperitoneal chemotherapy: the initial experience of a single centre study

scientific article published on 21 August 2019

Evaluation of reference genes and normalization strategy for quantitative real-time PCR in human pancreatic carcinoma.

scientific article published on January 2012

FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapy

artículo científico publicado en 2014

Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk

artículo científico publicado en 2016

G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab

artículo científico publicado en 2015

Gene Expression Profiling Reveals Novel Candidate Markers of Ovarian Carcinoma Intraperitoneal Metastasis.

artículo científico publicado en 2017

Gene expression of membrane transporters: Importance for prognosis and progression of ovarian carcinoma

artículo científico publicado en 2016

Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alterations

artículo científico publicado en 2019

Genetic determinants of telomere length and risk of pancreatic cancer: a PANDoRA study

artículo científico publicado en 2018

Genome-wide association study identifies an early onset pancreatic cancer risk locus

scientific article published on 09 April 2020

Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

artículo científico publicado en 2018

Human equilibrative nucleoside transporter 1 (hENT1): do we really have a new predictive biomarker of chemotherapy outcome in pancreatic cancer patients?

artículo científico

Lack of Replication of Seven Pancreatic Cancer Susceptibility Loci Identified in Two Asian Populations

article

Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction

artículo científico publicado en 2020

Protein expression of ABCC2 and SLC22A3 associates with prognosis of pancreatic adenocarcinoma

artículo científico publicado en 2019

Role of solute carrier transporters in pancreatic cancer: a review

artículo científico publicado en 2014

SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival

artículo científico publicado en 2017

Superoxide Dismutase and Nicotinamide Adenine Dinucleotide Phosphate

article

TERT gene harbors multiple variants associated with pancreatic cancer susceptibility

artículo científico publicado en 2015

Targeted Sequencing of Pancreatic Adenocarcinomas from Patients with Metachronous Pulmonary Metastases

artículo científico publicado en 2020

The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer.

artículo científico publicado en 2013

The association of taxane resistance genes with the clinical course of ovarian carcinoma.

artículo científico publicado en 2013

Therapeutic potential of taxanes in the treatment of metastatic pancreatic cancer

artículo científico publicado en 2016

Trends in peritoneal surface malignancies: evidence from a Czech nationwide population-based study

scientific article published on 06 November 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda